Yanjun Su

911 citations

56 papers · 644 indexed · h-index 15

Impact in

Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Endocrinology, Diabetes and Metabolism
- Thyroid Cancer Diagnosis and Treatment

Papers in ⓘ

Endocrinology, Diabetes and Metabolism 17
- Thyroid Cancer Diagnosis and Treatment 15
Cancer Research 12
- Cancer-related molecular mechanisms research 6
- MicroRNA in disease regulation 5

Co-authors: Michael H. Nathanson (1 shared paper)Roland Baron (1 shared paper)Munmun Chakraborty (1 shared paper)Changli Wang (3 shared papers)Zhenfa Zhang (3 shared papers)Changli Wang (7 shared papers)Ruochuan Cheng (18 shared papers)Xiubao Ren (2 shared papers)
Journals: Oncotarget (4 papers)World Journal of Surgical Oncology (2 papers)Frontiers in Oncology (2 papers)Frontiers in Endocrinology (2 papers)Clinical Epigenetics (1 paper)
Partner nations: China United States Germany

In The Last Decade

Yanjun Su

49 papers receiving 634 citations

Peers

Countries citing papers authored by Yanjun Su

Since Specialization

Citations

This map shows the geographic impact of Yanjun Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanjun Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanjun Su more than expected).

Fields of papers citing papers by Yanjun Su

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yanjun Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanjun Su. The network helps show where Yanjun Su may publish in the future.

Co-authors

The 25 scholars most cited alongside Yanjun Su, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Yanjun Su Line = papers co-authored together Yanjun Su links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 56 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Differential effects of the 3',5'-cyclic adenosine monophosphate and protein kinase C pathways on the response of isolated rat osteoclasts to calcitonin. Endocrinology ·Yanjun Su, Munmun Chakraborty, Michael H. Nathanson, Roland Baron	1992	70
2	MicroRNA‐130b targets PTEN to induce resistance to cisplatin in lung cancer cells by activating Wnt/β‐catenin pathway Cell Biochemistry and Function ·Qiang Zhang, Bin Zhang, Leina Sun, Qingna Yan, Yu Zhang, Zhenfa Zhang, Yanjun Su, Changli Wang	2018	51
3	Plasma miR-324-3p and miR-1285 as diagnostic and prognostic biomarkers for early stage lung squamous cell carcinoma Oncotarget ·Xujie Gao, Yang Wang, Hua Zhao, Feng Wei, Xinwei Zhang, Yanjun Su, Changli Wang, Hui Li, Xiubao Ren	2016	47
4	Identification of a three-miRNA signature as a blood-borne diagnostic marker for early diagnosis of lung adenocarcinoma Oncotarget ·Yang Wang, Hua Zhao, Xujie Gao, Feng Wei, Xinwei Zhang, Yanjun Su, Changli Wang, Hui Li, Xiubao Ren	2016	47
5	Increased prevalence of regulatory T cells in the lung cancer microenvironment: a role of thymic stromal lymphopoietin Cancer Immunology Immunotherapy ·Hui Li, Hua Zhao, Jinpu Yu, Yanjun Su, Shui Cao, Xiumei An, Xiubao Ren	2011	43
6	Talc mediates angiostasis in malignant pleural effusionsviaendostatin induction European Respiratory Journal ·N Najmunnisa, Kamal A. Mohammed, Scott C. Brown, Yanjun Su, Peruvemba Sriram, Brij Moudgil, R. Loddenkemper, Veena B. Antony	2007	39
7	Risk factors of central lymph node metastasis of papillary thyroid carcinoma Medicine ·Wen Liu, Ruochuan Cheng, Yanjun Su, Chang Diao, Jun Qian, Jianming Zhang, Yunhai Ma, Yinxia Fan	2017	37
8	The Function of SARI in Modulating Epithelial-Mesenchymal Transition and Lung Adenocarcinoma Metastasis PLoS ONE ·Changli Wang, Yanjun Su, Lianmin Zhang, Meng Wang, Jian You, Xiaoliang Zhao, Zhenfa Zhang, Jun Liu, Xishan Hao	2012	33
9	miR‑195 suppresses metastasis and angiogenesis of squamous cell lung cancer by inhibiting the expression of VEGF Molecular Medicine Reports ·Hailin Liu, Yulong Chen, Yue Li, Chenguang Li, Tingting Qin, Ming Bai, Zhenfa Zhang, Rui Jia, Yanjun Su, Changli Wang	2019	33
10	A survey on physician knowledge and attitudes towards clinical use of morphine for cancer pain treatment in China Supportive Care in Cancer ·Yanjun Su, Changli Wang, Weng Ling, Jennifer Catherine Ai-lian Woo, Kwauk Sabrina, Liu Chang, Lei Zhang	2009	30
11	Establishment and validation of the scoring system for preoperative prediction of central lymph node metastasis in papillary thyroid carcinoma Scientific Reports ·Wen Liu, Ruochuan Cheng, Yunhai Ma, Dan Wang, Yanjun Su, Chang Diao, Jianming Zhang, Jun Qian, Jin Liu	2018	27
12	Interferon-α2b gene-modified human bone marrow mesenchymal stem cells inhibit hepatocellular carcinoma by reducing the Notch1 levels Life Sciences ·Yanjun Su, Ruochuan Cheng, Jianming Zhang, Jun Qian, Chang Diao, Jianghua Ran, Hongqing Zhang, Li Li	2015	15
13	Cisplatin resistance in lung cancer is mediated by <italic>MACC1</italic> expression through PI3K/AKT signaling pathway activation Acta Biochimica et Biophysica Sinica ·Qiang Zhang, Bin Zhang, Leina Sun, Qingna Yan, Yu Zhang, Zhenfa Zhang, Yanjun Su, Changli Wang	2018	14
14	The strontium salt S12911 inhibits bone resorption in mouse calvaria and isolated rat osteoclasts cultures Bone and Mineral ·Yanjun Su, J Bonnet, P. Deloffre, Y Tsouderos, Ralf Baron	1992	14
15	Combining antiangiogenic therapy with neoadjuvant chemotherapy increases treatment efficacy in stage IIIA (N2) non-small cell lung cancer without increasing adverse effects Oncotarget ·Xiaoliang Zhao, Yanjun Su, Jian You, Liqun Gong, Zhenfa Zhang, Meng Wang, Zhenqing Zhao, Zhen Zhang, Xiaolin Li, Changli Wang	2016	14
16	Electrospinning With Lyophilized Platelet-Rich Fibrin Has the Potential to Enhance the Proliferation and Osteogenesis of MC3T3-E1 Cells Frontiers in Bioengineering and Biotechnology ·Jing Nie, Shumei Zhang, Peng Wu, Yuangang Liu, Yanjun Su	2020	13
17	Validation of EORTC QLQ-LC43 for Chinese patients with lung cancer Lung Cancer ·Lei Zhang, Yanjun Su, Yanni Hua, Weiran Liu, Lin Yue, Jinglian Wu, Le Luo, Wei‐Dong Lü, Stephanie Woo, Adam R. Miller, Shumin Xie, Hong Zhu, Chong Pang, Jing Zhang, Changli Wang	2014	12
18	Survival analysis of patients with non-small cell lung cancer who underwent surgical resection following 4 lung cancer resection guidelines BMC Cancer ·Dongsheng Yue, Liqun Gong, Jian You, Yanjun Su, Zhenfa Zhang, Zhen Zhang, Feng Gu, Meng Wang, Changli Wang	2014	11
19	Whole-exome sequencing identifies key mutated genes in T790M wildtype/cMET-unamplified lung adenocarcinoma with acquired resistance to first-generation EGFR tyrosine kinase inhibitors Journal of Cancer Research and Clinical Oncology ·Chenguang Li, Hailin Liu, Bin Zhang, Liqun Gong, Yanjun Su, Zhenfa Zhang, Changli Wang	2018	10
20	Potential interactions among myricetin and dietary flavonols through the inhibition of human UDP-glucuronosyltransferase in vitro Toxicology Letters ·Xichuan Li, Ce Wang, Jinqian Chen, Xia Hu, Hao Zhang, Zhiying Li, Bei Lan, Wei Zhang, Yanjun Su, Chunze Zhang	2022	9

About Yanjun Su

Yanjun Su is a scholar working on Endocrinology, Diabetes and Metabolism, Cancer Research, Nephrology, Oncology and Pulmonary and Respiratory Medicine, having authored 56 papers that have together received 644 indexed citations. Recurring topics across this work include Thyroid Cancer Diagnosis and Treatment (15 papers), Thyroid and Parathyroid Surgery (13 papers), Lung Cancer Diagnosis and Treatment (9 papers), Lung Cancer Treatments and Mutations (8 papers), Cancer-related molecular mechanisms research (6 papers), RNA modifications and cancer (5 papers), MicroRNA in disease regulation (5 papers) and Lung Cancer Research Studies (5 papers). The work is most often cited by research in Cancer Research (201 citations), Endocrinology, Diabetes and Metabolism (90 citations), Anesthesiology and Pain Medicine (28 citations), Oncology (127 citations) and Molecular Biology (288 citations). Yanjun Su has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Michael H. Nathanson, Roland Baron, Munmun Chakraborty, Changli Wang, Zhenfa Zhang, Changli Wang, Ruochuan Cheng, Xiubao Ren, Hua Zhao and Jianming Zhang. Their work appears in journals such as Oncotarget, World Journal of Surgical Oncology, Frontiers in Oncology, Frontiers in Endocrinology and Clinical Epigenetics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact